PAR:OSE

OSE Immunotherapeutics SA Stock Insider Trading

Euronext Paris > Healthcare > Biotechnology

5.94€

-0.370 (-5.86%)

At Close: Jun 21, 2024

OSE Immunotherapeutics SA Stock Insider Power

Based on the 0 latest insides trades, we have calculated the insider power to be negative at 0. In total, the insiders bought 0 and sold 0 OSE.PA shares in the last 0 trades.

Historical Insider Trades

There is currently no insider trading information for this ticker.

However, we invite you to learn more about this term and how to use this knowledge to benefit your trading strategy:

Sorry! Image not available at this moment

About OSE Immunotherapeutics SA

OSE Immunotherapeutics SA focuses on the development of immunotherapies for immune activation and regulation in the fields of immuno-oncology and autoimmune diseases. Its products include Tedopi that is in Phase III clinical stage for the treatment of non-small cell lung cancer, as well as in Phase II clinical trial to pancreatic and ovarian cancer; CoVepiT, a prophylactic vaccine against the SARS-CoV-2 virus; BI 765063, which is in Phase I clini... OSE.PA Profile

Golden Star

Ticker	Date	Change	Price
V	Jun 18	0.585%	$273.62
EPD	Jun 18	0.95%	$28.30
USFD	Jun 18	0.565%	$53.14
INTC	Jun 18	1.50%	$30.63
UFPT	Jun 18	3.45%	$253.79
^DJI	Jun 18	0.81%	38,834.86 points
BR	Jun 17	1.59%	$197.65
SARK	Jun 17	1.98%	$30.34
RGA	Jun 17	1.62%	$203.90
MA	Jun 17	1.50%	$448.11

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by

Sign In